Ublituximab (TG-1101), A Novel Anti-CD20 Monoclonal Antibody for Rituximab Relapsed/Refractory B-Cell Malignancies.

Drug Category : Array
Conference Category : Array
Lead Author : O'Connor O, Farber C, et al.
Published Date : 13/06/2014
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/EHA2014-PosterP444.PDF
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top